Newron Pharmaceuticals Statistics

Total Valuation

SWX:NWRN has a market cap or net worth of CHF 145.70 million. The enterprise value is 183.83 million.

Market Cap	145.70M
Enterprise Value	183.83M

Important Dates

The last earnings date was Tuesday, April 1, 2025.

Earnings Date	Apr 1, 2025
Ex-Dividend Date	n/a

Share Statistics

SWX:NWRN has 19.96 million shares outstanding. The number of shares has increased by 15.30% in one year.

Current Share Class	n/a
Shares Outstanding	19.96M
Shares Change (YoY)	+15.30%
Shares Change (QoQ)	+21.68%
Owned by Insiders (%)	5.40%
Owned by Institutions (%)	6.04%
Float	18.88M

Valuation Ratios

The trailing PE ratio is 10.11.

PE Ratio	10.11
Forward PE	n/a
PS Ratio	3.02
PB Ratio	106.52
P/TBV Ratio	106.52
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.43, with an EV/FCF ratio of -11.12.

EV / Earnings	12.37
EV / Sales	3.81
EV / EBITDA	7.43
EV / EBIT	7.49
EV / FCF	-11.12

Financial Position

The company has a current ratio of 2.60, with a Debt / Equity ratio of 34.62.

Current Ratio	2.60
Quick Ratio	2.42
Debt / Equity	34.62
Debt / EBITDA	1.91
Debt / FCF	-2.86
Interest Coverage	6.01

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	36.44%
Return on Invested Capital (ROIC)	46.45%
Return on Capital Employed (ROCE)	64.78%
Revenue Per Employee	2.19M
Profits Per Employee	675,612
Employee Count	22
Asset Turnover	1.14
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.67% in the last 52 weeks. The beta is 0.67, so SWX:NWRN's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	+1.67%
50-Day Moving Average	8.41
200-Day Moving Average	8.21
Relative Strength Index (RSI)	50.04
Average Volume (20 Days)	96,313

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SWX:NWRN had revenue of CHF 48.21 million and earned 14.86 million in profits. Earnings per share was 0.72.

Revenue	48.21M
Gross Profit	48.21M
Operating Income	24.55M
Pretax Income	20.07M
Net Income	14.86M
EBITDA	24.58M
EBIT	24.55M
Earnings Per Share (EPS)	0.72

Full Income Statement

Balance Sheet

The company has 9.22 million in cash and 47.35 million in debt, giving a net cash position of -38.13 million or -1.91 per share.

Cash & Cash Equivalents	9.22M
Total Debt	47.35M
Net Cash	-38.13M
Net Cash Per Share	-1.91
Equity (Book Value)	1.37M
Book Value Per Share	0.07
Working Capital	35.27M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -16.52 million and capital expenditures -12,196, giving a free cash flow of -16.54 million.

Operating Cash Flow	-16.52M
Capital Expenditures	-12,196
Free Cash Flow	-16.54M
FCF Per Share	-0.83

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 50.93% and 30.83%.

Gross Margin	100.00%
Operating Margin	50.93%
Pretax Margin	41.63%
Profit Margin	30.83%
EBITDA Margin	50.98%
EBIT Margin	50.93%
FCF Margin	n/a

Dividends & Yields

SWX:NWRN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.30%
Shareholder Yield	-15.30%
Earnings Yield	10.20%
FCF Yield	-11.35%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SWX:NWRN has an Altman Z-Score of 4.65.

Altman Z-Score	4.65
Piotroski F-Score	n/a